Research Roundup

Debbie Rigby rounds up the latest in research news Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of NOACs in patients with atrial fibrillation A meta-analysis of 15 studies has shown higher bleeding and mortality risks in NOAC-treated AF patients concomitantly using P-gp/CYP3A4 inhibitors. The risk of stroke, intracranial bleeding and gastrointestinal bleeding

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Shortage continues
Next NSW pharmacists recognised